Synapse - Alexander Drilon

Results (17)

Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies

Research Letter

Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
JAMA Oncology (2025)

Fulltext@MSK | Save

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development

Meeting Abstract

Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Journal Article

Gounder, M. M.; Agaram, N. P.; Trabucco, S. E.; Robinson, V.; Ferraro, R. A.; Millis, S. Z.; Krishnan, A.; Lee, J.; Attia, S.; Abida, W.; more...
Nature Communications (2022)

Fulltext@MSK | Save

Characterization and management of ERK inhibitor associated dermatologic adverse events: Analysis from a nonrandomized trial of ulixertinib for advanced cancers

Journal Article

Wu, J.; Liu, D.; Offin, M.; Lezcano, C.; Torrisi, J. M.; Brownstein, S.; Hyman, D. M.; Gounder, M. M.; Abida, W.; Drilon, A.; more...
Investigational New Drugs (2021)

Fulltext@MSK | Save

Clinical implications of drug-induced liver injury in early-phase oncology clinical trials

Journal Article

Mondaca, S. P.; Liu, D.; Flynn, J. R.; Badson, S.; Hamaway, S.; Gounder, M. M.; Khalil, D. N.; Drilon, A. E.; Li, B. T.; Jhaveri, K. L.; more...
Cancer (2020)

Fulltext@MSK | Save

Characterization of on-target adverse events caused by TRK inhibitor therapy

Journal Article

Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
Annals of Oncology (2020)

Fulltext@MSK | Save

Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements

Journal Article

Chang, J. C.; Zhang, L.; Drilon, A. E.; Chi, P.; Alaggio, R.; Borsu, L.; Benayed, R.; Travis, W. D.; Ladanyi, M.; Antonescu, C. R.
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma

Journal Article

Chiang, S.; Cotzia, P.; Hyman, D. M.; Drilon, A.; Tap, W. D.; Zhang, L.; Hechtman, J. F.; Frosina, D.; Jungbluth, A. A.; Murali, R.; more...
American Journal of Surgical Pathology (2018)

Fulltext@MSK | Save

A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel